TB500 peptide and injectable GHK-CU formulations are prohibited for compounding under current FDA regulations due to identified safety risks and insufficient human safety data
Some people report feeling improvements in energy, recovery, and overall vitalitywith guidance from Elases network of licensed medical providers
If you experience an adverse reaction to a dietary supplement, report it to the FDA's Safety Reporting Portal.
Pain during or after injection Some discomfort is normal, but injection should not be significantly painful
Motivators and barriers for dog and cat owners and veterinary surgeons in the United Kingdom to using preventative medicines
Regularly track your symptoms, including energy levels, fatigue, and any tingling or numbness, and report significant changes to your provider for appropriate adjustments